World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
59
Citations
15843
World Ranking
3221
National Ranking
1400

Overview

Kent W. Hunter is affiliated with the National Institutes of Health in the United States. Their research predominantly lies within the broad field of Biochemistry, Genetics and Molecular Biology, with a focus on several specialized subfields including Molecular Biology, Oncology, Cancer Research, Genetics, and Epidemiology.

The scientist's work covers diverse topics central to cancer biology and molecular mechanisms, including:

  • RNA modifications and cancer
  • Cancer Genomics and Diagnostics
  • RNA Research and Splicing
  • RNA and protein synthesis mechanisms
  • Cancer Cells and Metastasis
  • Epigenetics and DNA Methylation
  • Genomics and Chromatin Dynamics

Kent W. Hunter has published in a range of venues, with notable frequency in the following journals and platforms:

  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature (15 publications)
  • Cancer Research (6 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (4 publications)
  • PLoS Genetics (3 publications)
  • UNC Libraries (3 publications)

They have collaborated repeatedly with several co-authors, including:

  • Howard H. Yang (10 joint works)
  • Christina R. Ross (9 joint works)
  • Ruhul Amin (7 joint works)
  • Ngoc-Han Ha (6 joint works)
  • Maxwell P. Lee (5 joint works)

Some recent scientific papers authored or co-authored by Kent W. Hunter include:

  • In Vivo Evidence for Serine Biosynthesis-Defined Sensitivity of Lung Metastasis, but Not of Primary Breast Tumors, to mTORC1 Inhibition (2020, Molecular Cell)
  • Nuclear pore protein NUP210 depletion suppresses metastasis through heterochromatin-mediated disruption of tumor cell mechanical response (2021, Nature Communications)
  • The genomic landscape of metastasis in treatment-naïve breast cancer models (2020, PLoS Genetics)
  • Progesterone promotes immunomodulation and tumor development in the murine mammary gland (2021, Journal for ImmunoTherapy of Cancer)
  • Metastasis-Specific Gene Expression in Autochthonous and Allograft Mouse Mammary Tumor Models: Stratification and Identification of Targetable Signatures (2020, Molecular Cancer Research)

Best Publications

  • Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member

    J. David Brook;Mila E. McCurrach;Helen G. Harley;Alan J. Buckler

  • The Collaborative Cross, a community resource for the genetic analysis of complex traits

    Gary A. Churchill;David C. Airey;Hooman Allayee;Joe M. Angel

  • The genome architecture of the collaborative cross mouse genetic reference population

    Fuad A. Iraqi;Mustafa Mahajne;Yasser Salaymah;Hani Sandovski

  • Modeling metastasis in vivo.

    Chand Khanna;Kent Hunter

  • The nature and identification of quantitative trait loci: a community's view.

    Oduola Abiola;Joe M. Angel;Philip Avner;Alexander A. Bachmanov

  • Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence.

    Laura Vera-Ramirez;Suman K. Vodnala;Ryan Nini;Ryan Nini;Kent W. Hunter

  • The mouse fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster

    David H. Lynch;Mark L. Watson;Mark R. Alderson;Peter R. Baum

  • Mechanisms of metastasis

    Kent W Hunter;Nigel P S Crawford;Jude Alsarraj

  • Ezrin, a key component in tumor metastasis.

    Kent W. Hunter

  • Integrative Genomic Identification of Genes on 8p Associated With Hepatocellular Carcinoma Progression and Patient Survival

    Stephanie Roessler;Ezhou Lori Long;Anuradha Budhu;Yidong Chen

  • Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression

    Traci Lifsted;Thomas Le Voyer;Max Williams;William Muller

  • Genetic dissection of complex and quantitative traits: from fantasy to reality via a community effort.

    David W. Threadgill;Kent W. Hunter;Robert W. Williams

  • Initiating oncogenic event determines gene-expression patterns of human breast cancer models.

    Kartiki V. Desai;Nianqing Xiao;Weili Wang;Lisa Gangi

  • Bromodomain 4 activation predicts breast cancer survival

    Nigel P. S. Crawford;Jude Alsarraj;Luanne Lukes;Renard C. Walker

  • Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior.

    Alexander D. Borowsky;Ruria Namba;Lawrence J.T. Young;Kent W. Hunter

  • Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.

    Yeong-Gwan Park;Xiaohong Zhao;Fabienne Lesueur;Fabienne Lesueur;Douglas R Lowy

  • The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines.

    Cristina Montagna;Myung Soo Lyu;Kent Hunter;Luanne Lukes

  • Host genetics influence tumour metastasis

    Kent Hunter

  • Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1

    Yun-Liang Yang;Lei Guo;Shuang Xu;Shuang Xu;Christine A. Holland

  • Predisposition to Efficient Mammary Tumor Metastatic Progression Is Linked to the Breast Cancer Metastasis Suppressor Gene Brms1

    Kent W. Hunter;Karl W. Broman;Thomas Le Voyer;Luanne Lukes

Frequent Co-Authors

Maxwell P. Lee
Maxwell P. Lee National Institutes of Health
David W. Threadgill
David W. Threadgill Texas A&M University
Daniel Pomp
Daniel Pomp University of North Carolina at Chapel Hill
Ying Hu
Ying Hu National Institutes of Health
Gary A. Churchill
Gary A. Churchill The Jackson Laboratory
Danny R. Welch
Danny R. Welch University of Kansas
Elissa J. Chesler
Elissa J. Chesler University of Tennessee at Knoxville
Robert W. Williams
Robert W. Williams University of Tennessee Health Science Center
Fernando Pardo-Manuel de Villena
Fernando Pardo-Manuel de Villena University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Genetics opens doors to diverse careers in healthcare, research, and clinical practice. Many professionals interested in genetics also explore flexible online programs to further their expertise and career options. For those in nursing, an online rn to bsn no clinicals program enables registered nurses to earn a bachelor’s degree without time-consuming clinical placements.

Advanced nursing professionals may consider accelerated msn to dnp programs, which allow nurses to quickly move from a master’s to a doctoral level. These programs suit those wanting to focus on research or leadership roles, complementing work in genetics or related medical fields.

For those seeking entry-level medical roles, accelerated medical assistant programs can be completed in as little as six weeks. This can be a stepping stone to more advanced studies in genetics. Finally, students and professionals interested in the highest level of nursing education should explore dnp online options for maximum flexibility while pursuing top-tier credentials.

Best Scientists Citing Kent W. Hunter

Trending Scientists